TRANS-4-(TERT-BUTYL)CYCLOHEXANAMINE HCL, 95.0%, 250mg

2-Methoxy-5-(pentafluorosulfur)benzoic acid, 1g

4-(2-Carboxy-vinyl)-benzoic acid methyl ester, 1g

2-Bromo-6-(trifluoromethyl)phenol, 95.0%, 1g

(S)-Homoserine-lactone hydrochloride, 97.0%, 500g

(S)-(-)-[(Diphenyl)trimethylsiloxymethyl]pyrrolidine, 95+%, 1g

2-Cyclohexylpropan-2-yl Methacrylate (stabilized with Phenothiazine)>98.0%(GC)1g

2,6-Difluoro-nicotinic acid methyl ester, 95.0%, 5g

3-Methoxy-1,2-propanediol>98.0%(GC)25mL

N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiomorpholine-4-carboxamide, 98%, 100mg

Ralinepag, 99.70%, 10mg

N-(4-Chloro-3-methylphenyl)-4-methylbenzenesulfonamide, 95%, 100mg

trans-2-Nonenal>95.0%(GC)5mL